Watts Christopher R, Diviney Shelby S, Hamilton Amy, Toles Laura, Childs Lesley, Mau Ted
Department of Communication Sciences and Disorders, Texas Christian University, Fort Worth, Texas.
Department of Communication Sciences and Disorders, Texas Christian University, Fort Worth, Texas.
J Voice. 2015 Mar;29(2):191-9. doi: 10.1016/j.jvoice.2014.05.008. Epub 2014 Oct 12.
To investigate the efficacy of stretch-and-flow voice therapy as a primary physiological treatment for patients with hyperfunctional voice disorders.
Prospective case series.
Participants with a diagnosis of primary muscle tension dysphonia or phonotraumatic lesions due to hyperfunctional vocal behaviors were included. Participants received stretch-and-flow voice therapy structured once weekly for 6 weeks. Outcome variables consisted of two physiologic measures (s/z ratio and maximum phonation time), an acoustic measure (cepstral peak prominence [CPP]), and a measure of vocal handicap (voice handicap index [VHI]). All measures were obtained at baseline before treatment and within 2 weeks posttreatment.
The s/z ratio, maximum phonation time, sentence CPP, and VHI showed statistically significant (P < 0.05) improvement through therapy. Effect sizes reflecting the magnitude of change were large for s/z ratio and VHI (d = 1.25 and 1.96 respectively), and moderate for maximum phonation time and sentence CPP (d = 0.79 and 0.74, respectively).
This study provides supporting evidence for preliminary efficacy of stretch-and-flow voice therapy in a small sample of patients. The treatment effect was large or moderate for multiple outcome measures. The data provide justification for larger, controlled clinical trials on the application of stretch-and-flow voice therapy in the treatment of hyperfunctional voice disorders.
探讨伸展-流畅性嗓音治疗作为功能性嗓音障碍患者主要生理治疗方法的疗效。
前瞻性病例系列研究。
纳入诊断为原发性肌肉紧张性发声障碍或因功能性发声行为导致的发声创伤性病变的参与者。参与者接受每周一次、为期6周的结构化伸展-流畅性嗓音治疗。结果变量包括两项生理指标(s/z比值和最长发声时间)、一项声学指标(谐波峰值突出度[CPP])和一项嗓音障碍指标(嗓音障碍指数[VHI])。所有指标均在治疗前基线时及治疗后2周内获取。
通过治疗,s/z比值、最长发声时间、句子CPP和VHI均有统计学意义的改善(P < 0.05)。反映变化程度的效应量,s/z比值和VHI较大(分别为d = 1.25和1.96),最长发声时间和句子CPP中等(分别为d = 0.79和0.74)。
本研究为伸展-流畅性嗓音治疗在一小部分患者中的初步疗效提供了支持性证据。对于多项结果指标,治疗效果较大或中等。这些数据为开展关于伸展-流畅性嗓音治疗在功能性嗓音障碍治疗中应用的更大规模对照临床试验提供了依据。